1 Hobbs JG, et al. BMJ Open 2017;7:e016763. doi:10.1136/bmjopen-2017-016763 Open Access Protocol for a randomised crossover trial to evaluate patient and nurse satisfaction with electronic and elastomeric portable infusion pumps for the continuous administration of antibiotic therapy in the home: the Comparing Home Infusion Devices (CHID) study Jodie G Hobbs, 1 Melissa K Ryan, 1 Brett Ritchie, 2 Janet K Sluggett, 3,4 Andrew J Sluggett, 3,5 Lucy Ralton, 2 Karen J Reynolds 1 To cite: Hobbs JG, Ryan MK, Ritchie B, et al. Protocol for a randomised crossover trial to evaluate patient and nurse satisfaction with electronic and elastomeric portable infusion pumps for the continuous administration of antibiotic therapy in the home: the Comparing Home Infusion Devices (CHID) study. BMJ Open 2017;7:e016763. doi:10.1136/ bmjopen-2017-016763 ► Prepublication history and additional material are available. To view these fles please visit the journal online (http://dx.doi. org/10.1136/bmjopen-2017- 016763). Received 8 March 2017 Revised 31 May 2017 Accepted 14 June 2017 For numbered affliations see end of article. Correspondence to Karen J Reynolds; karen.reynolds@finders.edu.au Protocol ABSTRACT Introduction Previous studies comparing satisfaction with electronic and elastomeric infusion pumps are limited, and improvements in size and usability of electronic pumps have since occurred. The Comparing Home Infusion Devices (CHID) study plans to assess patient and nurse satisfaction with an elastomeric and electronic pump for delivering intravenous antibiotic treatment in the home. Secondary objectives are to determine pump-related complications and actual antibiotic dose administered, evaluate temperature variation and compare pump operating costs. Methods and analysis The CHID study will be a randomised, crossover trial. A trained research nurse will recruit patients with infectious disease aged ≥18 years and prescribed ≥8 days of continuous intravenous antibiotic therapy from the Royal Adelaide Hospital (RAH) (Adelaide, Australia). Patients will be randomised to receive treatment at home via an elastomeric (Baxter Infusor) or an electronic (ambIT Continuous) infusion pump for 4–7 days, followed by the other for a further 4–7 days. Patient satisfaction will be assessed by a 10-item survey to be completed at the end of each arm. Nurse satisfaction will be assessed by a single 24-item survey. Patient logbooks and case notes from clinic visits will be screened to identify complications. Pumps/infusion bags will be weighed to estimate the volume of solution delivered. Temperature sensors will record skin and ambient temperatures during storage and use of the pumps throughout the infusion period. Costs relating to pumps, consumables, antibiotics and servicing will be determined. Descriptive statistics will summarise study data. Ethics and dissemination This study has been approved by the RAH Human Research Ethics Committee (HREC/16/ RAH/133 R20160420, version 6.0, 5 September 2016). Study results will be disseminated through peer-reviewed publications and conference presentations. The CHID study will provide key insights into patient and provider satisfaction with elastomeric and electronic infusion pumps and inform future device selection. Trial registration number ACTRN12617000251325; Pre- results. BACKGROUND Ambulatory intravenous infusion of anal- gesics, chemotherapy and antimicrobials enables suitable patients to be treated in the home care setting, as an alternative to inpa- tient hospital care. 1 2 This reduces demand on hospital beds, provides cost savings and Strengths and limitations of this study ► Crossover randomised trial design to determine patient and nurse satisfaction with elastomeric and electronic infusion pumps for continuous infusions in the home setting. ► Measurement of ambient and skin temperature throughout the infusion period. ► Recording and analysis of pump, vascular access device and antibiotic complications, plus estimation of dose delivered. ► Home nursing staff have more experience using elastomeric infusion devices in comparison to electronic infusion devices. ► Unable to detect early emptying of elastomeric devices. ► Internal infusion solution temperature cannot be ascertained. group.bmj.com on November 9, 2017 - Published by http://bmjopen.bmj.com/ Downloaded from